Friday, 4 November 2016

Healthcare, Regulatory and Reimbursement Market Segmentation and Major Players Analysis 2022

The industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Italian pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases.

Italy’s population was 61.78 million in 2015, and is increasing due to a positive balance between the birth and death rates, as well as through immigration. The country’s policymakers are currently faced with the challenge of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market at the consumer price level (including Value Added Tax (VAT) and excluding hospital sales) was estimated at $22 billion in 2015, and is expected to decline to approximately $18 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 3.3%. The medical devices market was estimated at approximately $13.2 billion in 2015, and is expected to reach $16.2 billion by 2020, at a CAGR of 4.2%. The decline of Italy’s pharmaceutical market can primarily be attributed to -
- Owing to government measures to decrease healthcare expenditure
- Falling sales of patented drugs,
- Price cuts for drugs
- Government initiatives to promote generics
- The strict pricing of drugs through negotiations and through external reference pricing and internal reference pricing

The report provides information on Italy’s healthcare, regulatory and reimbursement landscape, and includes -
- An overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The major players covered for the pharmaceutical market are Menarini, Angelini, Chiesi, Bracco and Recordati. The major players covered for the medical devices market are DePuy Synthes, GlaxoSmithKline (GSK), Baxter, Essilor and Siemens Healthcare
- An insightful review of the country’s reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
- Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Italy’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Italy’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents
1 Table of Contents 7
    1.1 List of Tables 11
    1.2 List of Figures 15
2 Introduction 20
    2.1 GlobalData Report Guidance 20
3 Overview of Pharmaceutical and Medical Device Markets 21
    3.1 Pharmaceutical Market 21
      3.1.1 Market Overview 21
      3.1.2 Pharmaceutical Import and Export 23
      3.1.3 Supply Channels 25
      3.1.4 Market Segments 26
      3.1.5 Major Therapeutic Areas 31
      3.1.6 Major Companies 34
    3.2 Medical Device Market 74
      3.2.1 Market Overview 74
      3.2.2 Overview of Top Five Segments 76
      3.2.3 Diagnostic Market 87
      3.2.4 Major Companies 89
    3.3 Market Drivers and Barriers 125
      3.3.1 Drivers 125
      3.3.2 Barriers 127
4 Market Access 130
    4.1 Reimbursement and Payer Landscape 130
      4.1.1 Overview of Healthcare system 130
      4.1.2 Evolution of Healthcare System in Italy 135
      4.1.3 Reimbursement Process 138
      4.1.4 Overview of Insurance Providers 144
      4.1.5 Patient Share in Healthcare Spending 146
      4.1.6 Price Trends in the Healthcare Sector 149
      4.1.7 Pricing Policies 150
    4.2 Regulatory Landscape 152
      4.2.1 Overview of Regulatory Agencies 152
      4.2.2 Market Authorization Procedure for Pharmaceutical Products 153
      4.2.3 New Medical Device Approval Process 166
      4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 170
      4.2.5 Intellectual Property Rights 173
      4.2.6 Clinical Trial Regulations 176
      4.2.7 Pharmaceutical Advertising Regulations 180
      4.2.8 Pharmacy Regulations 183
      4.2.9 Labeling and Packaging Regulations 184
5 Country Analysis 187
    5.1 Political Environment 187
      5.1.1 Political Structure 187
      5.1.2 Analysis of the Current Political Environment 193
      5.1.3 Healthcare Policy Initiatives 195
    5.2 Economic Landscape 196
    5.3 Economic Indicators 199
      5.3.1 Gross Domestic Product 199
      5.3.2 Gross National Income 203
Contact Info:
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)                                                   

Get in touch:

No comments:

Post a Comment